Global Experts Meeting on

Clinical Diabetes and Nutrition

Bali, Indonesia   March 28-29, 2018

Call for Abstract

Diabetes is one of the most significant global health concerns of modern times. The causes of type 2 diabetes are multi-factorial and include both genetic and environmental elements that affect beta-cell function and tissue (muscle, liver, adipose tissue, and pancreas) insulin sensitivity. Several factors have been suggested as possibly linking insulin resistance and beta-cell dysfunction in the pathogenesis of Type 2 Diabetes. Many individuals suffering from type 2 diabetes are obese, with central visceral adiposity. According to the International Diabetes Federation, diabetes statistics says that there are more than 317 million people have been diagnosed with diabetes, and an additional 187 million are living undiagnosed. The global revenue earned from drugs sales to treat Type 2 Diabetes was approximately $36.89 billion in 2012 that is rapidly increasing in incidence and prevalence across the globe predicated to elevate this figure to approximately $68.42 billion by 2017. Patients with this disease cannot use glucose properly for their body needs. Latest research on Diabetes has led to the better living of the diabetic patients. In addition to this, self-monitoring of Blood glucose levels, lifestyle modifications and health eating habits are crucial in combating the critical manifestations of this disease which may require proper diabetic nursing. This may also include considerable amount of time educating patients and families on proper dietary, exercise and lifestyle habits to keep symptoms under control.

  • Track 1-1: Beta cell and Aging
  • Track 1-2: Aspects of non-beta cells in glucose homeostasis
  • Track 1-3: Aspects of DNA methylation in insulin secretion
  • Track 1-4: Genetic defects in insulin action
  • Track 1-5: Diabetes in particular ethnic groups

Novel therapeutic targets available for diabetes includes Incretin based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies.  Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management have been introduced recently with latest diabetes clinical trial going on which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction combating the complications of diabetes like Gestational Diabetes, Diabetes Myopathy, Diabetes cardiopathy and more.

  • Track 2-1: Novel models in Diabetic Complications
  • Track 2-2: Clinical diagnosis and laboratory views
  • Track 2-3: Diabetes, Prediabetes and Metabolic Syndrome
  • Track 2-4: Clinical trials on animal models
  • Track 2-5: Novel research and treatment specializations on diabetes
  • Track 2-6: Clinical presentation and diagnosis of diabetes mellitus in adults

Diabetes, regularly alluded as diabetes mellitus, depicts a gathering of metabolic maladies in which the individual has high blood glucose (blood sugar), it is either on the grounds that insulin creation is insufficient, or in light of the fact that the body's phones don't react appropriately to insulin, or both the sorts. People with high glucose will regularly encounter polyuria, they will turn out to be progressively parched (polydipsia) and hungry (polyphagia). The correct reason for sort 1 diabetes is obscure. What is known is that your invulnerable framework assaults and obliterates insulin-creating cells in the pancreas. This abandons you with almost no insulin. Rather than being transported into your cells, sugar develops in your circulation system. Sort 1 is thought to be brought on by a mix of hereditary helplessness and natural elements, however precisely what a large portion of those variables are is as yet indistinct. In prediabetes — which can prompt type 2 diabetes — and in type 2 diabetes, your cells wind up plainly impervious to the activity of insulin, and your pancreas can't make enough insulin to conquer this resistance. Rather than moving into your cells where it's required for vitality, sugar develops in your circulatory system.

  • Track 3-1: Genetics of metabolic syndrome
  • Track 3-2: Upcoming advances in genetics of diabetes
  • Track 3-3: Diabetes in specific ethnic groups
  • Track 3-4: Genetic-lifestyle interactions in the prevention of diabetes
  • Track 3-5: Understanding the genetics of diabetes

The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of lifestyles and obesity in global population. The diabetes treatment products include injectable diabetes drugs, oral drugs, insulin therapies, insulin pumps, insulin injection devices and blood glucose monitoring systems which eliminates the risk of reverse diabetes. According to the new report the world market for diabetes medications will reach $55.3bn in 2017. The anti-diabetic medicines industry generated $35.6bn in 2012, and its revenues will show strong growth to 2023. Monitoring glucose levels is critical for the management of diabetes and new and improved portable, less costly, easy-to-use, accurate and virtually painless blood glucose monitoring systems are now available to take control of the disease.

  • Track 4-1: Diabetes Medications, TZDs, and Combinations
  • Track 4-2: Better Second-Line Agent After Metformin: DPP-4 Inhibitors or SGLT-2 Inhibitors
  • Track 4-3: MODY and its types
  • Track 4-4: overviewing the Benefits and Risks of Diabetes Drugs
  • Track 4-5: Metabolic Syndrome genetics
  • Track 4-6: Second- and Third-Line Pharmacotherapy for Type 2 Diabetes
  • Track 4-7: Control of disease

Biomarkers can be defined as “a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers play an integral part in conducting clinical trials and treating patients. In most instances, they help medical practitioners, researchers, and regulatory officials make well-informed, scientifically sound decisions. More efficient discovery and use of biomarkers in the development of antidiabetic drugs will depend on advancing our understanding of the pathogenesis of diabetes and especially its macrovascular complications.  Methodological advances from other fields, especially oncology, are beginning to pave the way toward improved models of diabetes pathogenesis and biomarker discovery.

  • Track 5-1: Prognostic marker
  • Track 5-2: Diabetic nephropathy marker
  • Track 5-3: Molecular markers for both metabolic syndrome and hypoglycemia response
  • Track 5-4: Genetic lifestyle interaction in the development and prevention of diabetes

The research on diabetes leads to focus more on the diagnosis and treatment of diseases with the new approaches yet to be discovered or under developments. Maturity onset diabetes of the young, Diabetic Dyslipidemia is one of the major issues for the concern which is due to mutation. Without the pancreas producing this insulin, the sugar will stay in our blood and begin to create serious health issues. High blood sugar can cause blindness, kidney failure, nerve damage, and other organ function problems. There are various metabolic syndrome which are to be treated with recent tools for obesity and weight management is Bariatric surgery , stem cell therapy. With the development of software’s, now the computational tools i.e. bioinformatics is used for the analysis of data e.g. Sequence alignment, microarray analysis and specific tools mentioned. The researcher are also focusing on the metabolism of people with diabetes as it differs to the metabolism of people without diabetes.  In type 2 diabetes, the effectiveness of insulin is reduced and in type 1 diabetes, insulin levels in the body are very low. There is a strong correlation between BMI and body fat. One of the correlates of insulin resistance is the blood fatty acid (FA) level. FA levels are strong predictors of muscle insulin resistance. In diabetes for dummy's, it is vital to get tested regularly to make sure your normal blood sugar levels are safe. In the meantime, diabetes for dummies says to check your blood sugar levels, and know what they are.  Electron microscopy shows decreased mitochondrial size in muscle from individuals with type 2 diabetes.

  • Track 6-1: Obesity and diabetes
  • Track 6-2: Anti-diabetic Agents
  • Track 6-3: Bariatric Surgery & Obesity
  • Track 6-4: Diabesity - Methods to control or prevent diabetes in obese people
  • Track 6-5: New technologies for treating obesity
  • Track 6-6: Bioinformatics tools and techniques used in diabetes Research
  • Track 6-7: Diabetes and parkinsonism
  • Track 6-8: Epidemiology of diabetes in geriatric population
  • Track 6-9: Diabetic dyslipidemia
  • Track 6-10: Albuminuria

Cell therapy is defined as the administration of live whole cells or maturation of a specific cell population in a patient for the treatment of a disease. Cell therapy is expanding its repertoire of cell types for administration. Cell therapy treatment strategies include isolation and transfer of specific stem cell populations, administration of effector cells, induction of mature cells to become pluripotent cells, and reprogramming of mature cells. The establishment of pluripotent human embryonic stem cells and embryonic germ cells have introduced a new potential source for cell therapy in type 1 diabetic patients, especially in light of recent successes in producing glucose-sensitive insulin-secreting cells from mouse embryonic stem cells.

  • Track 7-1: Cure for Type 1 Diabetes Stem Cells
  • Track 7-2: Embryonic stem cell therapy for diabetes and its complications
  • Track 7-3: Beta Cells in Type 1 Diabetes
  • Track 7-4: Mechanisms of Pancreatic β-Cell in Type 1 and Type 2 Diabetes
  • Track 7-5: Diabetes stem cell

Nutrition therapy is a necessary part of the treatment and self-administration of diabetes. The objectives of Nutrition therapy are to keep up or enhance personal satisfaction and wholesome and physiological wellbeing, to anticipate and treat intense and long-haul inconveniences of diabetes, related comorbid conditions and corresponding disorders. It is well recognized that nutrition therapy can enhance glycemic control by decreasing glycated hemoglobin and when utilized with different constituents of diabetes care, can enhance clinical and metabolic results bringing about diminished hospitalization rates. Besides, follow up with a dietician has related to better dietary adherence in type II diabetes.

  • Track 8-1: Glycemic index
  • Track 8-2: Glycemic control
  • Track 8-3: Macronutrient intake
  • Track 8-4: Diabetic complexity
  • Track 8-5: Total carbohydrate intake

The exact causes of diabetes are still not fully understood, it is known that obesity features up the threat of developing different types of diabetes mellitus. For type 2 diabetes, this includes being overweight or obese (having a BMI of 30 or greater). In fact, obesity is believed to account for 80-85% of the threat of type II diabetes development, while recent research suggests that obese people are up to 80 times more inclined to develop type II diabetes than those with a BMI of less than 22. Studies suggest that abdominal fat reasons for the fat cells to discharge pro-inflammatory chemicals, which can make the body less sensitive to the insulin it produces by hindering the functionality of insulin responsive cells and their ability to respond to insulin. 

  • Track 9-1: Inflammatory response
  • Track 9-2: Insulin resistance
  • Track 9-3: Interruption in fat metabolism
  • Track 9-4: Physical activities and lifestyle
  • Track 9-5: Diet plan and Nutritional implications
  • Track 9-6: Hemodialysis and diabetes nutrition

Diabetes is a long-term condition which can influence the life of an individual. It mainly affects kids in their development and advancement and enthusiastic prosperity. Worldwide there is a clear increment in its occurrence for kids particularly below 5 populaces. years old. Furthermore, this illness, may expand the danger of creating miniaturized scale vascular and full scale –vascular inconveniences. T1d is well-known interminable ailments starting in the adolescence and records for more than 90% of the instances of youth diabetes, with a general predominance rate of 0.2-0.5% over the Caucasoid.

  • Track 10-1: Growth hormone deficiency
  • Track 10-2: Puberty disorders
  • Track 10-3: Pituitary and hypopituitarism
  • Track 10-4: Obesity in children

Gestational diabetes otherwise called gestational diabetes mellitus (GDM), is a condition in which a lady without diabetes grows high glucose levels amid pregnancy. Gestational diabetes by and large outcomes in expanding the danger of requiring a Cesarean area. Babies destined to such moms with ineffectively treated gestational diabetes are at expanded danger of having low glucose after birth, and jaundice. On the off chance that untreated, it might prompt stillbirth. In long haul odds of creating type 2 diabetes may increment in that people.
Gestational diabetes is created because of insufficient insulin in the setting of insulin resistance. Chance variables incorporate being overweight and having polycystic ovarian disorder. Analysis is finished by blood tests. For those patients at ordinary hazard for the most part screening will be done in the vicinity of 24 and 28 weeks growth.

  • Track 11-1: Corticosteroids
  • Track 11-2: Mild and moderate nonproliferative diabetic retinopathy
  • Track 11-3: Severe and proliferative nonproliferative diabetic retinopathy
  • Track 11-4: Visual acuity testing
  • Track 11-5: Monitoring fetal growth and well-being
  • Track 11-6: Prognosis
  • Track 11-7: Managing self-care
  • Track 11-8: Etiology and pathogenesis
  • Track 11-9: Insulin shots
  • Track 11-10: Vitrectomy

Diabetes is a metabolic disorder in which the person has high blood glucose (blood sugar), either because insulin production is inadequate. Long-term complications of diabetes like diabetic cholesterol develop gradually. The longer we have diabetes, and the less controlled our blood sugar, the higher the risk of complications to skin & immune system, cardiovascular diseases, and nerve damage. Diabetes and alcohol will cause your blood sugar to rise and alcohol has a lot of calories. Patients with diabetes will typically experience various complications like Diabetic Macular Edema, people with diabetes also facing one of the major complication that is diabetic foot having problems like ulceration, polyuria, infection or neuropathic osteroarthropathy, polydipsia, Alzheimer's disease, polyphagia and even more. Diabetes being the one of the causes of death in world and results into other health complication caused like blindness and kidney failure.

  • Track 12-1: Microvascular complications: Retinopathy, neuropathy, and nephropathy
  • Track 12-2: Diabetic Myelopathy
  • Track 12-3: Diabetic Mastopathy
  • Track 12-4: Hypertension
  • Track 12-5: Pediatric diabetes and treatment
  • Track 12-6: Gestational diabetes and treatment
  • Track 12-7: Immune intervention in type 1 diabetes
  • Track 12-8: Type 2 diabetes -Complications and treatment
  • Track 12-9: Type 1 diabetes -Complications and treatment
  • Track 12-10: Diabetic gastroparesis

There are several different types of diabetes drugs - with some having similar ways of acting. Drugs which act similarly to each other are put into the same class of drugs.Insulin is a hormone which helps to regulate blood sugar. Many different types of insulin are available as medication, with some insulins acting for as long as a day and others acting for only a few hours.Biguanides / Metformin-The only available diabetes medication in the biguanides class of drugs is metformin. Biguanides prevent the liver from producing glucose and helps to improve the body’s sensitivity towards insulin. Metformin is commonly used as a first line treatment for type 2 diabetes and may occasionally be prescribed, in combination with insulin, for people with type 1 diabetes. Insulin, Biguanides / Metformin, Sulphonylureas, Meglitinides / Prandial glucose regulator / Glinides Alpha-glucosidase inhibitors, Thiazolidinedione /Glitazones, DPP-4 inhibitors / Gliptins, Incretin mimetics/GLP-1 analogues Amylin analogues are the other drugs used for treatment of diabetes.

  • Track 13-1: Oral glucose lowering treatment
  • Track 13-2: Insulin and its analogues
  • Track 13-3: Different drug for diabetic patients
  • Track 13-4: Advanced products
  • Track 13-5: Tele medicine
  • Track 13-6: Ayurvedic and herbal medicines

An estimated 7.8 percent of the U.S. population has diabetes, a chronic disorder affecting the body’s metabolism. The most common form is type 2 diabetes, affecting approximately 90–95 percent of those with the disease. Type 2 diabetes is most often associated with older age, obesity, a family history of diabetes, physical inactivity, and certain ethnicities (NDIC, 2008). In addition, new research has also improved our understanding of the genetic underpinnings of type 2 diabetes. The diagnosis of type 2 diabetes includes the identification of insulin resistance, or the body’s inability to process insulin, which ultimately results in a buildup of glucose in the body. In contrast to type 1 diabetes, the symptoms of type 2 diabetes develop slowly over time. Recent research focuses on preventing or delaying type 2 diabetes in at-risk populations and has revealed that lifestyle interventions and some medications can reduce the development of diabetes

  • Track 14-1: Clinical trials to prevent disease
  • Track 14-2: Test a new drug
  • Track 14-3: New treatment for diabetes
  • Track 14-4: Trialnet
  • Track 14-5: GRADE
  • Track 14-6: RISE
  • Track 14-7: FNIH biomarkers

Diabetes education is the cornerstone of diabetes management, because diabetes requires day-to-day knowledge of nutrition, exercise, monitoring, and medication, Importance of Diabetes Education.Diabetes is unlike other diseases, such as cholesterol and hypertension, where medication alone can often successfully treat it.  There are a lot of other components to diabetes, such as: the diabetes disease process, nutritional management, physical activity, medications, glucose monitoring, and psychosocial adjustment.Diabetes education makes you more aware of diabetes, what it takes to treat it, and gives you the power to control it.  Diabetes education allows you to better incorporate education into your life and make the necessary changes to improve your lifestyle.

  • Track 15-1: Self-Management Education
  • Track 15-2: Diabetes and Lifestyle Intervention
  • Track 15-3: Pharmacotherapy
  • Track 15-4: Diabetes Management Education